Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis
Pregnancy in women with paroxysmal nocturnal hemoglobinuria (PNH) is associated with increased maternal and fetal morbidity and mortality. There is limited published experience regarding therapy of PNH during pregnancy. We describe a case of a 30 year old female with hypoplastic myelodysplastic synd...
Main Authors: | Ruby Sharma, Alla Keyzner, Johnson Liu, Thomas Bradley, Steven L. Allen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Leukemia Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048915000059 |
Similar Items
-
Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description
by: Endri Mauro, Filippo Gherlinzoni
Published: (2019-11-01) -
Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria: A Case Report and Literature Review
by: Saito M, et al.
Published: (2020-07-01) -
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation
by: Ferras Alashkar, et al.
Published: (2020-09-01) -
Positive impact of eculizumab therapy on surgery for Budd- Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria and a longterm history of thrombosis
by: Silvia De-la-Iglesia, et al.
Published: (2016-09-01) -
A novel patient-reported outcome instrument assessing the symptoms of paroxysmal nocturnal hemoglobinuria, the PNH-SQ
by: R. Paola Daly, et al.
Published: (2021-09-01)